111 records matched your query
03341aam a2200373 i 4500 001 B2E2B934F5D411E7B33F7C0497128E48 003 SILO 005 20180110010212 008 160714t20162016flua b 001 0 eng d 010 $a 2016427612 020 $a 1498748503 020 $a 9781498748506 035 $a (OCoLC)930255403 040 $a BTCTA $b eng $e rda $c BTCTA $d DLC $d YDXCP $d BAL $d BDX $d OCLCF $d IaU-L $d UtOrBLW $d SILO 042 $a lccopycat 043 $a n-us--- $0 http://id.loc.gov/vocabulary/geographicAreas/n-us 050 00 $a RA401.A3 $b P54 2016 082 00 $a 362.17/82 $2 23 245 00 $a Pharmaceutical public policy / $c [edited by] Thomas R. Fulda, MA, Alan Lyles, ScD, MPH, RPh, Henry A. Rosenberg Professor of Government, Business and Noprofit Partnerships, University of Baltimore, Fellow, National Academy of Public Administration, Docent, University of Helsinki; Albert I. Wertheimer, PhD, MBA, Professor of Pharmaceutical Economics, Department of Pharmacy Practtice, Temple University School of Pharmacy, Philadelphia, PA. 264 1 $a Boca Raton : $b CRC Press, Taylor & Francis Group, $c [2016] 300 $a xv, 497 pages : $b illustrations ; $c 26 cm 500 $a "A Productivity Press book." 520 $a "Pharmaceutical Public Policy provides the understanding and framework required for effective organization, financing, and delivery of pharmaceutical products and services. It supplies an overview of the policy process as well as the roles of legislation and regulation in pharmaceutical policy.The book identifies the goals, objectives, and key policy issues of concern to stakeholders involved in the development of products, use of pharmaceuticals in healthcare, and administration of insurance programs by both the private and government sectors. Policy issues examined include the appropriateness of prescribing and patient adherence. Addressing questions of access, quality, and cost, the book considers the operation of the Affordable Care Act and Medicare Part D. It details the responsibilities of Federal providers of pharmaceutical care and private and public payers such as managed care organizations, pharmacy benefit managers, Medicare, and Medicaid. The book covers the policies and practices involved in promoting pharmaceutical products. It also considers pharmacoeconomics as a response to market failure. Finally, the book describes the market, the role of the manufacturer, drug shortages, and the responsibilities of the FDA"--Publisher's description. 504 $a Includes bibliographical references and index. 650 0 $a Pharmaceutical policy $z United States. $0 http://id.loc.gov/authorities/subjects/sh2008109173 650 7 $a Pharmaceutical policy. $2 fast $0 (OCoLC)fst01060194 651 7 $a United States. $2 fast $0 (OCoLC)fst01204155 700 1 $a Fulda, Thomas R., $e editor. $0 http://id.loc.gov/authorities/names/n2007180130 700 1 $a Lyles, Alan, $e editor. $0 http://id.loc.gov/authorities/names/no2007058696 700 1 $a Wertheimer, Albert I., $e editor. $0 http://id.loc.gov/authorities/names/n80118348 776 08 $i Online version: $a Fulda, Thomas R. $t Pharmaceutical public policy. $d Boca Raton : CRC Press, 2016 $z 9781498748513 $w (OCoLC)948247010 941 $a 1 952 $l OVUX522 $d 20180110031042.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=B2E2B934F5D411E7B33F7C0497128E48Initiate Another SILO Locator Search